Quest Diagnostics' Sonora Quest Labs Announces Leadership Change with Jennifer Erickson as CEO-Elect
- Jennifer Erickson has been appointed CEO-Elect of Sonora Quest Laboratories, succeeding long-time leader David Dexter.
- Under Dexter, Sonora Quest became Arizona's top clinical laboratory, performing over 100 million tests annually.
- Erickson aims to enhance patient-centered diagnostics and strengthen community health partnerships during her leadership.
Leadership Transition at Sonora Quest Laboratories Promises Continuity and Growth
Sonora Quest Laboratories has recently announced the appointment of Jennifer Erickson as Chief Executive Officer-Elect, marking a significant leadership transition within the organization. She will succeed David Dexter, who has held the CEO position for over 26 years and plans to retire on March 31, 2026. Under Dexter's leadership since 1999, Sonora Quest has grown to be Arizona's leading clinical laboratory testing provider, performing over 100 million diagnostic tests each year. His tenure is characterized by key innovations such as the launch of the direct-access testing platform, My Lab ReQuest™, and the expansion of COVID-19 testing services through Operation Catapult, solidifying the laboratory's role in crucial public health initiatives.
Erickson brings over two decades of experience in health care and consumer services to her new role. Having served as CFO of Sonora Quest from 1999 to 2004, she has deep familiarity with the company and its operations. Her recent leadership positions, including CFO and COO of Clin-Path Associates/Pathology Specialists of Arizona, have further prepared her to lead Sonora Quest in an evolving healthcare landscape. Dexter has expressed full confidence in Erickson's capabilities, emphasizing her understanding of the company's collaborative culture and commitment to accountability, which will be vital as she steers the organization through its next chapter of growth and innovation.
As the healthcare industry continues to evolve, Erickson's strategic focus will likely center on enhancing patient-centered diagnostics while fostering robust partnerships within the healthcare community. With the groundwork laid by Dexter, she aims to build on existing relationships and explore new collaborations that can further enhance the quality of diagnostic testing services. The transition in leadership at Sonora Quest not only signifies a change at the helm but also reflects the ongoing commitment to excellence in laboratory services that the organization has upheld for decades.
In other news, Sonora Quest's recent initiatives highlight its commitment to community health. The laboratory's partnership with the American Cancer Society and CommunityCares aims to increase access to important diagnostic services, ensuring that individuals receive timely and necessary testing. The continuity of leadership under Erickson is expected to support these initiatives and further enhance the company's role in promoting public health in Arizona and beyond.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

